The Case for Semaglutide on Subscription
Long-term research protocols demand consistent, uninterrupted compound supply. A gap in availability mid-protocol can compromise weeks or months of work — not because the compound degrades, but because the protocol itself depends on temporal consistency. This is especially true for semaglutide research, where its 168-hour half-life supports once-weekly dosing in protocols designed for steady-state pharmacokinetics.
Yet until BeaCapra, no research peptide supplier offered automated delivery. Researchers were left to manually reorder, track inventory, and hope their supplier had stock when they needed it. BeaCapra's subscribe & save program changes this equation entirely.
How Subscribe & Save Works
Step 1: Choose Your Compound
Select semaglutide (or any of BeaCapra's 24 research peptides) and toggle the "Subscribe & Save" option on the product page.
Step 2: Set Your Frequency
Choose delivery every 30, 60, or 90 days based on your protocol timeline. The 30-day option aligns with semaglutide's reconstituted stability window (30 days at 2-8°C in BAC water).
Step 3: Save 15%
Every subscription order receives an automatic 15% discount. For semaglutide, that's $110.49 per vial versus the $129.99 one-time price — a saving of $19.50 per delivery.
Total Control
- Skip any delivery with one click — no penalty
- Swap to a different compound anytime
- Pause your subscription for 30, 60, or 90 days
- Change frequency at any time
- Cancel permanently — no contracts, no fees, no retention games
- Payment reminder 3 days before each renewal
Why This Matters for Semaglutide Research
Protocol Continuity
Semaglutide reaches steady-state plasma concentrations in 4-5 weeks of once-weekly administration. Interrupting compound supply after steady-state is achieved means the protocol must restart — the compound's 168-hour half-life means circulating levels decline to near-zero within 4-5 weeks of discontinuation. Automated delivery eliminates the procurement gap that causes these restarts.
Budget Predictability
Subscription pricing converts variable research supply costs into a fixed, predictable budget line. At $110.49/month (30-day frequency), the annual semaglutide supply cost is $1,325.88 — versus $1,559.88 at the one-time price. That's $234 saved per year on a single compound.
| Scenario | One-Time Price | Subscribe Price | Annual Savings |
|---|---|---|---|
| Semaglutide, monthly | $1,559.88/yr | $1,325.88/yr | $234.00 |
| Semaglutide, every 60 days | $779.94/yr | $662.94/yr | $117.00 |
| Semaglutide + Tirzepatide, monthly | $3,359.76/yr | $2,855.76/yr | $504.00 |
Freshness Guarantee
Reconstituted semaglutide in BAC water is stable for 30 days at 2-8°C. A monthly subscription ensures you're always working with freshly reconstituted material, rather than stretching a vial beyond its stability window. Each delivery arrives with a batch-specific COA documenting the exact purity of your material.
No Stockouts
Popular peptides — particularly semaglutide and tirzepatide — experience periodic supply constraints across the industry. Subscription orders are prioritized in BeaCapra's fulfillment pipeline, ensuring your research doesn't stall because of inventory fluctuations.
Who Should Subscribe
- Researchers running protocols longer than 4 weeks: Any protocol that extends beyond a single vial benefits from automated replenishment
- Labs with multiple ongoing studies: Subscription across several compounds eliminates the administrative burden of repeated purchasing
- Budget-conscious programs: 15% savings compound over time, especially for multi-compound protocols
- Anyone who has ever run out mid-protocol: The cost of a delayed study far exceeds the cost of having compound arrive automatically
Why No Other Supplier Offers This
The research peptide industry has historically operated as a commodity market: suppliers list products, researchers buy when they need them, and there's no ongoing relationship beyond the transaction. This model works for occasional purchasers but fails researchers running sustained protocols.
BeaCapra was built with a different assumption: that serious research is not a one-time event. Protocols run for weeks, months, or longer. Compound supply should match the temporal structure of the research, not the transactional structure of a retail store. Subscribe & save is the infrastructure built around that assumption.
As of 2026, no other research peptide supplier offers subscription delivery on semaglutide or any other compound. This remains BeaCapra's most distinctive structural advantage.
Getting Started
- Visit the Semaglutide product page
- Toggle "Subscribe & Save" (pre-selected by default)
- Select your frequency: every 30, 60, or 90 days
- Add to cart — the 15% discount applies automatically
- Your first order ships same-day (before 2PM EST); subsequent orders ship on schedule with a 3-day advance reminder
Frequently Asked Questions
Can I cancel my semaglutide subscription anytime?
Yes. Cancel with one click from your account dashboard. No cancellation fees, no contracts, no retention calls. Your subscription stops immediately.
What if I have too much compound?
Skip your next delivery or change your frequency from monthly to every 60 or 90 days. You can also pause for up to 90 days and resume when ready.
Can I change what compound I'm subscribed to?
Yes. Swap your subscription to any BeaCapra product at any time from your account dashboard. The 15% discount applies to all compounds.
When am I charged?
You receive an email reminder 3 days before each subscription renewal. Payment is processed automatically on the renewal date. You can skip or cancel before the charge processes.
Do subscription orders get a COA?
Yes. Every subscription delivery includes a batch-specific Certificate of Analysis, the same as one-time orders. Each shipment may come from a different batch, and each batch has its own COA.
All BeaCapra products are sold for research use only. Not for human consumption.